Skip to content

Clinical trial of fire-needle combined with medicated thread moxibustion of Zhuang medicine in the treatment of Verruca Plana

Fire Needle Combined with Medicated Thread Moxibustion of Zhuang Medicine for the Treatment of Verruca Plana Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075618
Enrollment
Unknown
Registered
2023-09-11
Start date
2023-09-11
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Verruca Plana

Interventions

treatment group:fire-needle combined with medicated thread moxibustion of Zhuang medicine
control group:Topical treatment with retinoic acid cream

Sponsors

Hangzhou Lin'an District Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria (1) Compliance with western medical diagnostic criteria; (2) Age between 18-60 years old; (3) Skin lesions are mainly on the face; (4) Not receiving relevant medication within 1 month prior to treatment, and not receiving physical therapy such as laser and cryotherapy within 2 months prior to treatment; (5) Informed consent and sign the informed consent form. Note: Only those who met the above 5 could be included in the study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (1) Flat warts combined with other skin diseases; (2) Those who cannot be treated on time and followed up regularly; (3) Keloid and allergic body, especially those who are allergic to vitamin A and its derivatives; (4) Women who are preparing for pregnancy, pregnant and lactating; (5) Those who have participated or are participating in other clinical trials 1 month prior to participation in this study; (6) Those with severe heart, liver and other serious organ damage; (7) People with mental illness or cognitive impairment. Note: If any 1 of the above criteria is met, they will be excluded.

Design outcomes

Primary

MeasureTime frame
Skin lesion scores before and after treatment;Clinical Efficacy Score;Wound healing;Security assessment;

Countries

China

Contacts

Public ContactQingqing Zhu

Hangzhou Lin'an District Hospital of Traditional Chinese Medicine

zhenjiuzqq@163.com+86 156 5883 8762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026